PharmaCyte Biotech
PMCB0.40010.94% ( -0.0038 )
Forecast & RatingOnly 1 analyst currently covers PharmaCyte Biotech (PMCB.US), with a rating of "Hold". The sample is very small, so treat this as a reference only. Data as of Dec 8, 2025; this does not constitute investment advice.
Oct 7, 2022Price forecast
--100.00%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
No data available at the moment
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.